FGF21 and metabolic dysfunction-associated steatotic liver disease: There may also be a plausible biological link with non-alcoholic fatty liver disease (NAFLD), given that FGF21 decreases TGs, improves insulin sensitivity and counters obesity by suppressing weight gain, the major risk factor for NAFLD [49, 51].